key: cord-0820859-7fwlcsh8 authors: Ali, Mohammad; Bonna, Atia Sharmin; Sarkar, Abu-sufian; Islam, Md. Ariful; Rahman, Nur-A- Safrina title: SARS-CoV-2 infection is associated with low back pain: Findings from a community based case-control study date: 2022-05-25 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2022.05.050 sha: 4894739c771658c61d16887f33cf7bbf27881a14 doc_id: 820859 cord_uid: 7fwlcsh8 Objective : Pain is a significant complaint of post-acute COVID-19 patients; however, little is known about the association between SARS-CoV-2 infection and pain. This study aimed to (1) examine the association between SARS-CoV-2 infection and low back pain (LBP) and (2) identify independent predictors of LBP among COVID-19 survivors. Method : This case-control study involved 878 participants aged ≥18 years. Data were collected from February 24 to April 7, 2022, in Bangladesh. LBP was measured using the musculoskeletal subscale of subjective health complaints produced by Eriksen et al. Descriptive analysis was done to compute LBP prevalence and compare them across groups. Multiple logistic analyses helped to identify the predictors of LBP for COVID-19 survivors. Results : Overall, 20% of participants reported LBP; however, the prevalence of LBP was significantly high among post-acute COVID-19 patients compared to their counterparts (24.4% vs. 15.7%, p=0.001). Regression analysis for all participants suggested that the SARS-CoV-2 infection was independently associated with LBP (AOR=1.837, 95% CI=1.253 to 2.692). However, moderate COVID-19 illness (AOR=1.754, 95% CI=0.984 to 3.126) was the only statistically significant predictor of LBP. Conclusion : SARS-CoV-2 infection was associated with LBP, and moderate COVID-19 symptom was an independently associated factor of LBP. The healthcare facilities must be prepared to deal with the burden of LBP among post-acute COVID-19 patients. Low back pain (LBP) is a widespread public health concern and the leading cause of disability worldwide (Hartvigsen et al., 2018) . The monetary influence of LBP is inter-sectoral since it raises expenses in both healthcare and social support systems (Carregaro et al., 2020) . A 2015 study revealed that 540 million people were affected by activity-limiting LBP at any one time, giving a global prevalence of 7.3% . In Bangladesh, the prevalence of LBP was 36.6% among sedentary office workers (Ali et al., 2020 (Ali et al., , 2021c . Previously, LBP was thought to be the problem of industrialized nations, and the prevalence of LBP was significantly high in high-income countries (Freburger et al., 2009) . However, in the past few decades, the most significant increases in disability caused by LBP have occurred in low-income and middleincome countries, including Asia, Africa, and the Middle East (Hoy et al., 2015) . The global point prevalence of LBP was 8.20% in 1990 and decreased slightly to 7.50% in 2017; nonetheless, in Africa, the point prevalence of LBP has increased from 32% in 2006 to 39% in 2017 (Louw et al., 2007; Morris et al., 2018; Vos et al., 2017) . As a result, the whole world was experiencing a wave of the subtle pandemic of LBP. Subsequently, the world is experiencing the unprecedently prolonged coronavirus disease-2019 pandemic. Since 2019, about 7% (0.52 billion) of the world population has already been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the number is increasing every minute (World Health Organization, 2021) . Furthermore, a significant portion of COVID-19 patients are asymptomatic and thus do not know about their illness (Ma et al., 2021) . Consequently, the actual number of COVID-19 patients will be much higher than the estimated number, and an enormous portion of the world population will be bearing the health consequences of post-acute COVID-19 syndromes. A previous study suggested that COVID-19 impacted sufferers' health even if asymptomatic (Long et al., 2020) . A range of conditions such as extreme tiredness, shortness of breath, chest pain, the problem with memory and concentration, insomnia, heart palpitation, dizziness, joint pain, high temperature, caught, headache and depression, and anxiety were identified as very common in post-acute COVID-19 patients (Nalbandian et al., 2021) . Similarly, a large samplesize cohort study revealed that 57% of COVID-19 survivors were suffering from long-COVID. The overall incidence of pain (of any kind) recorded after COVID-19 was 34.2% (Taquet et al., 2021) . Pain, therefore, appears to be a prominent and relatively persistent element of long-COVID (Bileviciute-Ljungar et al., 2022) . However, very little is known about the specific impact of SARS-CoV-2 infection on the world's leading cause of pain-related disability that is LBP. Therefore, this study aimed to (1) examine the association between SARS-CoV-2 infection and LBP and (2) identify independent predictors of LBP among post-acute COVID-19 patients. In this case-control study, individuals who were previously infected by SARS-CoV-2 were considered as 'case', and those who never tested positive for COVID-19 were considered as 'control'. Data were collected from apparently healthy ambulatory Bangladeshi individuals aged 18 years and above for both case and control. The specific eligibility criteria of the participants of this study were as follows: We include an individual who was  Apparently healthy A confidence level of 95%, a response distribution of 50%, and a margin of 5% error were used to determine the sample size to target 1.9 million laboratory-tested COVID-19 positive individuals in Bangladesh (World Health Organization, 2021) and secure a minimum sample size of 385 participants for case data (Ali and Hossain, 2021) . The Ethical Review Committee of Uttara Adhunik Medical College and Hospital formally approved the study. Prospective registration for the case-control study was obtained from the WHO endorsed Clinical Trial Registry-India: CTRI/2022/02/040449 [Registered on 21/02/2022]. The STROBE guideline for the case-control study was followed strictly throughout the study. All the invited participants were required to provide informed consent for participation, collection, and analysis of their data. Acute COVID-19 usually lasts until four weeks from the onset of symptoms, beyond which replication-competent SARS-CoV-2 has not been isolated. Post-acute COVID-19 is defined as persistent symptoms and delayed or long-term complications beyond four weeks from the onset of symptoms (Nalbandian et al., 2021) . In this study, we have collected data (for cases) from the individuals who tested positive at least six weeks ago. Therefore, the patients were considered post-acute COVID survivors after six weeks of acute symptoms. Data was collected using a paper-based questionnaire comprised of four parts. The first part of the questionnaire asked a wide range of sociodemographic questions, including gender, age, marital status, education, employment status, monthly household income in Bangladeshi taka (BDT), and present address. In the second part, participants were asked whether they had a chronic disease diagnosis (e.g., hypertension, diabetes, kidney disease, and asthma), whether they were present tobacco users, and regularly performed physical exercise. These questions were answered by choosing between dichotomous options (yes/no). In the third part (only for case data), participants were asked to provide information about their COVID-19 illness. Information about the symptoms appeared during COVID-19 (mild, moderate, severe, and very severe), facilities used to treat the patient (home, hospital's general word, or hospital's intensive care unit), and the COVID-19 vaccine dose they received (no vaccine, one dose, two doses or three doses) were recorded. The information about symptoms of the COVID-19 was taken from the medical records preserved by the participants. The period (in days) after recovery from acute COVID-19 was also recorded. The last part of the questionnaire measured the complaints about LBP. The questions on LBP were based on the musculoskeletal subscale of subjective health complaints produced by Eriksen et al. that measured LBP complaints experienced in the last 30 days (Ali et al., 2020 (Ali et al., , 2021a Eriksen et al., 1999) . Participants were asked to rate the occurrence of pain in the lower back with four answering categories. The severity of each complaint is rated on a 4-point scale (0=none, 1=some, 2=much, 3=severe). Each complaint is also scored for the duration (number of days) during the last 30 days. Severity X duration has often been used to obtain a total score (0-90), indicating the degree of complaint (Ali et al., 2021b; Eriksen et al., 1999) . In this study, participants who had a complaint of at least some pain for three days (1 X 3= 3) in the last month and scored ≥3 were considered to have LBP (Ali et al., 2020) . Finally, the participants were asked whether their low back pain arose or worsened after SARS-CoV-2 infection (Yes/No). Six expert data collectors collected the data. First, ten government-approved COVID-19 testing centers were conveniently selected in different locations in Bangladesh. Second, the data collector gathered particulars of randomly selected 600 (60 from each center) subjects aged 18 and above who were previously tested positive for COVID-19; however, have no active illness. Considering inclusion and exclusion criteria, 450 subjects were found to be eligible for this study. Finally, participants who consented to have their data collected underwent individual faceto-face interviews at their homes or workplaces; therefore, 439 case data was secured. In contrast, control subjects were chosen from the case's eligible family members, neighborhoods, or office colleagues. As a result, 439 age and gender-matched individuals who provided informed consent were interviewed face to face. All data were collected from February 24 to April 7, 2022. The participants and the public were not involved in our research's design, conduct, reporting, and dissemination plans. This study's aim and objective were explained, and assurance of anonymity was given before receiving informed consent from the participants. Data were analyzed using SPSS V.22.0 (IBM) software. Chi-squared tests were used to compare categorical variables with and without LBP. To compute adjusted odds ratios (AORs) with a 95% confidence interval (CI), multiple logistic regression analyses were performed with LBP as a dependent variable and sociodemographic characteristics, clinical and COVID-19 illnessrelated factors as predictor variables for LBP. Variables were found statistically significant in the descriptive analysis of all data included in the regression model-1. Similarly, regression model-2 consisted of variables found statistically significant in the descriptive analysis of case data. The Hosmer-Lemeshow goodness-of-fit test was used to ensure that the models adequately fit the data. P-values ≤0.05 were considered statistically significant. Overall, 878 individuals (50.5% women) mean age of 38.30 ±SD 12.77 years participated in this study. For 439 (50% of all participants) cases, the mean age ±SD was 38.33 ±12.53 years, whereas the mean age ±SD was 38.28 ±13.01 years for the controls. Contrarily, 49.2% and 51.7% of women participated in the case and control groups. The majority of the participants were married (81.3%), with a bachelor's degree (34.1%), service holder (33.7%), had a monthly household income BDT>45 thousand (42.5%), from a nuclear family (66.6%), lived in the city (61.5%). However, only 24.0% had hypertension, 23.5% had diabetes, 10.3% had kidney disease, and 16.4% had asthma. Furthermore, only 19.8% and 38.8% of participants reported that they performed regular physical exercise and were current tobacco users, respectively. Results are shown in Table 1 . Similarly, primary analysis of case data suggested that the majority of the participants were married (83.8%), with a bachelor's degree (33.9%), service holder (34.4%), had a monthly household income BDT>45000 (45.1%), from the nuclear family (67.9%), lived in the city (54.4%). However, only 27.3% had hypertension, 26.7% had diabetes, 14.4% had kidney disease, and 23.9% had asthma. Furthermore, only 24.4% and 44.9% of participants reported that they perform regular physical exercise and current tobacco users, respectively. In addition, the majority of the post-acute COVID-19 patients were tested negative for the illness for more than 180 days (36.7%), had suffered from mild COVID-19 (49.9%), taken treatment at home (65.1%), and received two doses COVID-19 vaccine (41.9%) before catching the disease. (Table 2) . The overall prevalence of LBP was 20%; however, the prevalence was significantly higher among the participants who were tested positive for COVID-19 than their counterparts (24.4% vs. 15.7%, p=0.001). In addition, for all data, statistically significant higher prevalence was found in women (23.0%, p=0.026), person aged over 60 (27.3%, p=0.016), divorced/widow (40.0%, p=0.005), participants who received high school or lower education (32.1%, p=<0.001), homemaker (29.9%, p=<0.001), those with a monthly household income